MiRNA Dysregulation in Childhood Hematological Cancer.
Jaqueline Carvalho de OliveiraGabriela Molinari RobertoMirella BaroniKarina Bezerra SalomãoJulia Alejandra PezukMaría Sol BrassescoPublished in: International journal of molecular sciences (2018)
For decades, cancer biology focused largely on the protein-encoding genes that have clear roles in tumor development or progression: cell-cycle control, apoptotic evasion, genome instability, drug resistance, or signaling pathways that stimulate growth, angiogenesis, or metastasis. MicroRNAs (miRNAs), however, represent one of the more abundant classes of cell modulators in multicellular organisms and largely contribute to regulating gene expression. Many of the ~2500 miRNAs discovered to date in humans regulate vital biological processes, and their aberrant expression results in pathological and malignant outcomes. In this review, we highlight what has been learned about the roles of miRNAs in some of the most common human pediatric leukemias and lymphomas, along with their value as diagnostic/prognostic factors.
Keyphrases
- cell cycle
- prognostic factors
- gene expression
- papillary thyroid
- endothelial cells
- childhood cancer
- squamous cell
- cell proliferation
- signaling pathway
- genome wide
- cell death
- poor prognosis
- small molecule
- dna methylation
- type diabetes
- binding protein
- cell therapy
- young adults
- stem cells
- metabolic syndrome
- oxidative stress
- vascular endothelial growth factor
- pi k akt
- adipose tissue
- anti inflammatory
- multidrug resistant
- bioinformatics analysis
- induced apoptosis